Genome Editing using CRISPR/Cas9 Mini-symposium


CRISPR based genome editing technologies are revolutionizing academia, life science and are expected to found the basis for next generation gene therapies.

Note! Click on the button "Tilmeld" to register for the event. The button will take you to the PhD site for University of Copenhagen, where you can read more about this event (see column to the right og the PhD site).

This years mini-symposium will focus on the latest developments in the use of CRISPR/Cas9, repurposed Cas9 based technologies and their use in whole animal and translational research. The conference will include sessions on use of CRISPR/Cas9 based applications in :

- Drug screening

- Animal models

- Therapeutics

- Future tools and directions

Confirmed speakers:

Jacob Corn, Berkeley, USA/ETH in Zurich, Ch

Patrick Hsu, The Salk Institute, USA

Katherine Pawelczak , NERx Biosciences, Inc, USA

Marie Christine Birling, Phenomin ICS, Strasbourg, Fr

Vincenzo DiDonato, ZeClinics, Es

Ed Ryan, Welcome Trust Sanger Institute, Cambridge, GBR

Carol Elvira, ThermoFisher, USA

Gurpreet Balrey, Merckgroup, UK

Thomas Tiilmark Eriksen, Lundbeck A/S, Dk

Massimo Squatrito, cnio, Es

Information
  • When

    7. dec. 2018 09:00 - 17:00
  • Where

    Panum Instituttet, Mærsk Tower, Blegdamsvej 3b, 2200 København N

  • Registration Deadline

    1. dec. 2018 - 23:55

  • Organizer

    IDA Bioteknologi

  • Available Seats

    139

  • Event Number

    329157